---
title: "Ribbon Acquisition Corp - Unit | 10-Q: FY2025 Q2 EPS: USD 0.11"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252913440.md"
datetime: "2025-08-13T20:09:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252913440.md)
  - [en](https://longbridge.com/en/news/252913440.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252913440.md)
generator: "portal-rs"
---

# Ribbon Acquisition Corp - Unit | 10-Q: FY2025 Q2 EPS: USD 0.11

EPS: As of FY2025 Q2, the actual value is USD 0.11.

### Segment Revenue

-   The company has not generated any operating revenues as of June 30, 2025, since it is a blank check company focused on identifying a target for a business combination.

### Operational Metrics

-   For the three months ended June 30, 2025, the company reported a net income of $271,297, which included operating expenses of $242,894 and income earned on marketable securities held in the Trust Account of $514,191.
-   For the six months ended June 30, 2025, the company reported a net income of $507,153, with operating expenses of $428,295 and income earned on marketable securities held in the Trust Account of $935,448.

### Cash Flow

-   Net cash used in operating activities for the six months ended June 30, 2025, was - $418,288.
-   Net cash used in investing activities was - $50,000,000, primarily due to the purchase of marketable securities held in the Trust Account.
-   Net cash provided by financing activities was $50,710,916, which included proceeds from the sale of public units and private placements.

### Unique Metrics

-   The company completed its Initial Public Offering (IPO) on January 16, 2025, raising gross proceeds of $50,000,000 through the sale of 5,000,000 units at $10.00 per unit.
-   Simultaneously, a private placement of 220,000 units was completed, generating additional proceeds of $2,200,000.

### Future Outlook and Strategy

-   **Core Business Focus**: The company is focused on completing a business combination within 12 months from the IPO date, using the proceeds from the IPO and private placement to finance the acquisition and subsequent operations of the target business.
-   **Non-Core Business**: The company has entered into a Business Combination Agreement with DRC Medicine Inc., DRC Medicine Ltd., and DRC Merger Inc., which involves a series of transactions to merge and domesticate as a Delaware corporation.
-   The company has until January 16, 2026, to complete the business combination, failing which it will liquidate and return funds to shareholders.

### Related Stocks

- [RIBBU.US](https://longbridge.com/en/quote/RIBBU.US.md)

## Related News & Research

- [Crypto platform on alert lists opens Hong Kong office, prompting calls for scrutiny](https://longbridge.com/en/news/302948940.md)
- [Saratoga Investment - Corporate bond price target increased by 13.78% to $37.75](https://longbridge.com/en/news/302950487.md)
- [AI fever ignites a boom in thematic ETFs as fund managers hunt for their next big hit](https://longbridge.com/en/news/302963080.md)
- [Oracle Stocks Edge Up as $1 Billion Backs AI Partners](https://longbridge.com/en/news/302919901.md)
- [Memory Stocks Are Plummetting. Jensen Huang Says the Bears Have It Wrong.](https://longbridge.com/en/news/302948213.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**